Proposal 1 - To approve an amendment to our Fourth Amended and Restated Certificate of Incorporation,as amended, to effect a reverse split of our outstanding common stock at a ratio in the range of 1-for-50 to1-for-100, to be determined at the discretion of our Board of Directors, whereby each outstanding 50 to100 common shares would be combined, converted and changed into 1 share of our common stock, to enable the Company to comply with the Nasdaq Stock Market’s continued listing requirements;
• Proposal 2 - To approve an amendment to the Company’s 2017 Equity Incentive Plan to provide that the Incentive Stock Option Limit set forth in Section 3(c) of the Company’s 2017 Equity Incentive Plan shall not be subject to adjustment pursuant to the applicable provisions of Section 9(a)(i) of the Company’s 2017 Equity Incentive Plan in connection with the reverse stock split effected by the Company on October 16, 2020 or the first reverse stock split effected by the Company following December 5, 2022; and
• Proposal 3 - To authorize one or more adjournments of the special meeting to solicit additional proxies in the event there are insufficient votes to approve Proposal 1 and Proposal 2 described above.
Recent NUWE News
- Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health • GlobeNewswire Inc. • 04/09/2024 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/11/2024 09:08:24 PM
- Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference • GlobeNewswire Inc. • 03/07/2024 02:08:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 05:02:05 PM
- Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/05/2024 01:00:00 PM
- U.S. Futures Dip, Crude Oil Fluctuates • IH Market News • 03/05/2024 11:05:54 AM
- Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024 • GlobeNewswire Inc. • 02/27/2024 02:00:00 PM
- Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™ • GlobeNewswire Inc. • 02/22/2024 12:58:00 PM
- Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/20/2024 10:06:53 PM
- Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics Conference • GlobeNewswire Inc. • 02/20/2024 01:42:52 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/08/2024 10:19:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 02:07:29 PM
- New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload • GlobeNewswire Inc. • 02/06/2024 02:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/09/2024 10:30:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 02:24:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:25:39 PM
- Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter • GlobeNewswire Inc. • 01/04/2024 08:05:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 09:05:26 PM
- New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients • GlobeNewswire Inc. • 11/28/2023 01:00:00 PM
- Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/14/2023 09:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 03:00:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 01:15:43 PM
- Nuwellis, Inc. Announces Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/07/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 08:15:20 PM
- Nuwellis Announces Board of Directors Transition • GlobeNewswire Inc. • 11/01/2023 12:00:00 PM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM